Wnt/β-catenin agonist 1

Wnt/β-catenin agonist 1 Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Guangzhou Ruidi Biotechnology Co., Ltd.  
Tel: 020-82099279 18988941402
Email: sales@ubiochem.com

Wnt/β-catenin agonist 1 manufacturers

Wnt/β-catenin agonist 1 Basic information
Product Name:Wnt/β-catenin agonist 1
Synonyms:Wnt/β-catenin agonist 1;Wnt/β catenin agonist 1,Wnt/βcatenin agonist 1;9-Phenanthridinol, 8-[(1,3-dimethyl-1H-pyrazol-5-yl)methoxy]-5-ethyl-5,6-dihydro-4-methyl-
CAS:2305372-67-0
MF:C22H25N3O2
MW:363.45
EINECS:
Product Categories:
Mol File:2305372-67-0.mol
Wnt/β-catenin agonist 1 Structure
Wnt/β-catenin agonist 1 Chemical Properties
Boiling point 580.8±50.0 °C(Predicted)
density 1.21±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
pka9.11±0.20(Predicted)
form Solid
color White to light yellow
Safety Information
MSDS Information
Wnt/β-catenin agonist 1 Usage And Synthesis
Description

Wnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC50 of 0.27 μM[1].

EC50: 0.27 μM (Wnt/β-catenin)[1].

UsesWnt/β-catenin agonist 1 (compound 3f) is a Wnt/β-catenin signalling pathway agonist, with an EC50 of 0.27 μM[1].
References

[1]. Chen DZ, et al. Design, synthesis and structure-activity relationship optimization of phenanthridine derivatives as new Wnt/β-catenin signalling pathway agonists. Bioorg Chem. 2019 Mar;84:285-294.

Wnt/β-catenin agonist 1 Preparation Products And Raw materials
Tag:Wnt/β-catenin agonist 1(2305372-67-0) Related Product Information
6-amino-8-[3-bromo-5-methoxy-4-(prop-2-en-1-yloxy)phenyl]-8H-[1,3]dioxolo[4,5-g]chromene-7-carbonitrile 8H-1,3-Dioxolo[4,5-g][1]benzopyran-7-carbonitrile, 6-amino-8-(3-bromo-4,5-dimethoxyphenyl)- Wortmannin-Rapamycin Conjugate 3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[2-(1H-pyrazol-1-yl)ethyl]- 3-Isoxazolecarboxamide, 5-(4-fluorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- Wnt pathway activator 2